• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    New PPO Dental Plans More Competitive Against HMOs

    6/11/25 10:07:00 AM ET
    $CI
    $HUM
    $MET
    Medical Specialities
    Health Care
    Medical Specialities
    Health Care
    Get the next $CI alert in real time by email

    LOS ANGELES, June 11, 2025 /PRNewswire/ -- DentalInsurance.com, the leader in dental insurance comparison shopping, has broadened its inventory of PPO dental plans offering high maximum benefits. A maximum benefit is the annual cap on insurance company spending toward a consumer's covered dental care. PPO plans have a maximum benefit limit while HMO dental insurance doesn't. PPOs, however, have much wider dentist networks than most competing HMO plans. This helps consumers receive quality dental care from a trusted preferred dentist. By adding high maximum benefits, a new generation of PPO dental plans have become an even more attractive option for consumers.

    DentalInsurance.com logo, helping people find the coverage they need at an affordable price. (PRNewsfoto/DentalInsurance.com)

    Traditionally PPO plans have maximum benefits around $2,000 annually. If the cost of covered dental care exceeds that amount, it is the responsibility of the enrollee to pay. With this new generation of PPO plans, maximum benefit increases range from 25 percent to 400 percent higher ($2,500 to $10,000 in total).

    "High maximum benefit PPO plans have become an essential part of our business," commented DentalInsurance.com President Avery Smith. "Many consumers aren't satisfied with the wider dentist network of a PPO unless the coverage comes with solid protection against high out-of-pocket costs."

    DentalInsurance.com offers a variety of high maximum dental plans from top brands such as MetLife (NYSE:MET), Cigna Cigna (NYSE:CI), Humana Humana (NYSE:HUM), Guardian, and Delta Dental:

    • NCD Complete by MetLife ($10,000 maximum benefit)
    • Humana Extend 5000 ($5,000 maximum benefit)
    • NCD Elite 5000 by MetLife ($5,000 maximum benefit)
    • Delta Dental Immediate Coverage Plan ($3,000 maximum benefit)
    • Guardian Advantage Premier ($3,000 maximum benefit)
    • Cigna Dental Vision Hearing 3500 ($2,500 maximum benefit on dental work with separate limits on additional hearing and vision benefits)
    • Delta Dental Dental for Everyone Platinum ($2,500 maximum benefit)
    • Anthem BlueCross Essential Choice Incentive ($2,500 maximum benefit)

    Consumers shopping for high maximums should always read insurance conditions to see if a maximum excludes any service or is lower on a particular category of care (e.g. braces). For more detailed on dental plans with high maximum benefits, see Dental Plans with the Best Maximum Benefits.

    Launched in 2001 by Mark Kelsey, DentalInsurance.com is the pioneer of the online dental insurance marketplaces. DentalInsurance.com is headquartered in Los Angeles, California, and boasts an A+ rating from the Better Business Bureau and a 4.8 stars out of 5 on TrustPilot.

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/new-ppo-dental-plans-more-competitive-against-hmos-302478365.html

    SOURCE DentalInsurance.com

    Get the next $CI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CI
    $HUM
    $MET

    CompanyDatePrice TargetRatingAnalyst
    Humana Inc.
    $HUM
    2/12/2026$189.00Outperform → Sector Perform
    RBC Capital Mkts
    Humana Inc.
    $HUM
    2/2/2026$174.00Equal-Weight → Underweight
    Morgan Stanley
    Humana Inc.
    $HUM
    1/7/2026$290.00Overweight → Equal Weight
    Wells Fargo
    MetLife Inc.
    $MET
    1/6/2026$97.00Outperform → In-line
    Evercore ISI
    MetLife Inc.
    $MET
    12/16/2025$101.00Outperform
    Mizuho
    Humana Inc.
    $HUM
    12/5/2025$313.00Hold → Buy
    Jefferies
    Humana Inc.
    $HUM
    10/14/2025$235.00Sell
    Goldman
    The Cigna Group
    $CI
    10/14/2025$370.00Buy
    Goldman
    More analyst ratings

    $CI
    $HUM
    $MET
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman & CEO Cordani David bought $999,916 worth of shares (4,134 units at $241.88) (SEC Form 4)

    4 - Cigna Group (0001739940) (Issuer)

    11/3/25 2:47:56 PM ET
    $CI
    Medical Specialities
    Health Care

    President & CEO Rechtin James A. bought $1,496,984 worth of Humana Common (6,530 units at $229.25) (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    5/16/25 4:48:13 PM ET
    $HUM
    Medical Specialities
    Health Care

    Mesquita Jorge S. bought $200,066 worth of Humana Common (545 units at $367.09) (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    2/21/24 10:37:23 AM ET
    $HUM
    Medical Specialities
    Health Care

    $CI
    $HUM
    $MET
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Humana downgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts downgraded Humana from Outperform to Sector Perform and set a new price target of $189.00

    2/12/26 8:16:45 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Humana from Equal-Weight to Underweight and set a new price target of $174.00

    2/2/26 6:49:06 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded Humana from Overweight to Equal Weight and set a new price target of $290.00

    1/7/26 8:56:48 AM ET
    $HUM
    Medical Specialities
    Health Care

    $CI
    $HUM
    $MET
    SEC Filings

    View All

    SEC Form 13F-HR filed by MetLife Inc.

    13F-HR - METLIFE INC (0001099219) (Filer)

    2/12/26 5:08:16 PM ET
    $MET
    Life Insurance
    Finance

    Humana Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - HUMANA INC (0000049071) (Filer)

    2/11/26 6:40:24 AM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form 144 filed by The Cigna Group

    144 - Cigna Group (0001739940) (Subject)

    2/6/26 2:05:58 PM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    $HUM
    $MET
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Evernorth Health Services Teams Up with Direct Relief To Deliver Critical Medications to Communities Impacted by Disasters

    Evernorth's home delivery pharmacy donated more than 41,000 prescription medications to Direct Relief for initial supply Collaboration creates a scalable, replicable model for pharmacies to support disaster preparedness and future humanitarian responseBLOOMFIELD, Conn., Feb. 12, 2026 /PRNewswire/ -- Evernorth, the health services division of The Cigna Group (NYSE:CI), has partnered with Direct Relief to donate more than 41,000 lifesaving prescription medications for rapid deployment during natural disasters and other emergencies. Through this collaboration, Evernorth's Express Scripts Pharmacy has created a first–of–its–kind donation pathway that enables humanitarian organizations to source

    2/12/26 9:00:00 AM ET
    $CI
    Medical Specialities
    Health Care

    Humana Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Financial Guidance

    Reports 4Q25 net loss per share of $6.61 on a GAAP basis, Adjusted net loss per share of $3.96; reports full year (FY) 2025 earnings per share (EPS) of $9.84 on a GAAP basis, $17.14 on an Adjusted basis; quarterly and FY Adjusted results in line with management's expectations 4Q25 Insurance segment GAAP benefit ratio of 93.1 percent; FY 2025 Insurance segment GAAP benefit ratio of 90.4 percent, slightly better than guidance of 'the top end of the range of 90.1 percent to 90.5 percent' Introduces FY 2026 GAAP EPS guidance of 'at least $8.89'; 'at least $9.00' on an Adjusted basis; the anticipated year-over-year decline results from the Star Ratings headwind for Bonus Year 2026, net of

    2/11/26 6:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Named KCTCS Education First Employer, Announces Humana Scholars Program for Nursing Students

    Humana is investing in a new program with Jefferson Community and Technical College to strengthen and support Kentucky's nursing workforce. In announcing the launch of the Humana Scholars program, Humana joins the Kentucky Community and Technical College System (KCTCS) network of Education First Employers, partnering with the system's Louisville campus, Jefferson. Humana is investing a total of $125,000 in the Humana Scholars program, which includes two components – a Scholarship Fund and a Student Support Fund – to help train and support a pipeline of skilled nurses. The program will offer both scholarships and help reduce barriers, like food insecurity or lack of transportation, for f

    2/5/26 10:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    $CI
    $HUM
    $MET
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Martin Aaron claimed no ownership of stock in the company (SEC Form 3)

    3 - HUMANA INC (0000049071) (Issuer)

    1/27/26 9:30:40 AM ET
    $HUM
    Medical Specialities
    Health Care

    President & CEO Rechtin James A. converted options into 2,183 units of Humana Common and covered exercise/tax liability with 980 units of Humana Common (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    1/12/26 9:42:43 AM ET
    $HUM
    Medical Specialities
    Health Care

    Director Kennard William E was granted 639 shares, increasing direct ownership by 1% to 45,415 units (SEC Form 4)

    4 - METLIFE INC (0001099219) (Issuer)

    1/6/26 4:11:06 PM ET
    $MET
    Life Insurance
    Finance

    $CI
    $HUM
    $MET
    Leadership Updates

    Live Leadership Updates

    View All

    VINCENT COUNTRY SAFE ZONE ACTIVITY DAY PRESENTED BY CIGNA HEALTHCARE DELIVERS SUPER BOWL WEEK FUN, NFL FLAG FOOTBALL, AND WELLNESS TO OAKLAND STUDENTS

    Corporate, Nonprofit, and Philanthropic Partners Collaborated to Provide Transformative Experiences and Lasting Resources at Burckhalter Elementary School OAKLAND, Calif., Feb. 3, 2026 /PRNewswire/ -- Vincent Country Safe Zone Activity Day Presented by Cigna Healthcare, a flagship initiative of Love Thy Neighbor CDC co-founded by NFL Executive and Legend Troy Vincent, Sr. and his wife, author and chef Tommi A. Vincent, took place Tuesday, February 3, at Burckhalter Elementary School in Oakland, CA. The ninth annual event, themed Dreams Grow Here, delivered a full day of fun, food, wellness, and engaging sports activities, including NFL FLAG, for more than 200 Pre-K through fifth-grade studen

    2/3/26 8:17:00 PM ET
    $CI
    Medical Specialities
    Health Care

    MetLife Investment Management Completes Acquisition of PineBridge Investments

    The combination brings together global scale and deep specialization, accelerating MetLife's growth in asset management MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE:MET), closed today on its acquisition of PineBridge Investments (PineBridge). The combined business manages $734.7 billion1 of assets, serving clients around the world. Accelerating growth in asset management is a top priority for MetLife in its New Frontier strategy. The acquisition brings together MIM's institutional strength and scale with PineBridge's global footprint and deep specialization to position MIM as a top-tier diversified global asset manager. "Toget

    12/30/25 5:15:00 AM ET
    $MET
    Life Insurance
    Finance

    Humana Announces Insurance Leadership Transition

    George Renaudin to Retire as Insurance Segment President by Q3 2026 Aaron Martin to Join as President of Medicare Advantage and Insurance Segment President Successor John Barger to Succeed Martin as President of Medicare Advantage Humana Inc. (NYSE:HUM) today announced that George Renaudin, Insurance Segment President and member of Humana's Enterprise Leadership Team, will retire by Q3 2026 following a successful 29-year career at the company. During this period, Renaudin played a pivotal role in establishing and growing Humana's Medicare Advantage and Medicaid programs, helping to build them into high-performing businesses and assembling a strong insurance leadership team. "George has co

    12/16/25 8:05:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    $CI
    $HUM
    $MET
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by The Cigna Group

    SC 13G - Cigna Group (0001739940) (Subject)

    11/12/24 9:55:14 AM ET
    $CI
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13D/A filed by MetLife Inc.

    SC 13D/A - METLIFE INC (0001099219) (Subject)

    11/1/24 5:05:26 PM ET
    $MET
    Life Insurance
    Finance

    Amendment: SEC Form SC 13D/A filed by MetLife Inc.

    SC 13D/A - METLIFE INC (0001099219) (Subject)

    8/1/24 4:38:49 PM ET
    $MET
    Life Insurance
    Finance

    $CI
    $HUM
    $MET
    Financials

    Live finance-specific insights

    View All

    Humana Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Financial Guidance

    Reports 4Q25 net loss per share of $6.61 on a GAAP basis, Adjusted net loss per share of $3.96; reports full year (FY) 2025 earnings per share (EPS) of $9.84 on a GAAP basis, $17.14 on an Adjusted basis; quarterly and FY Adjusted results in line with management's expectations 4Q25 Insurance segment GAAP benefit ratio of 93.1 percent; FY 2025 Insurance segment GAAP benefit ratio of 90.4 percent, slightly better than guidance of 'the top end of the range of 90.1 percent to 90.5 percent' Introduces FY 2026 GAAP EPS guidance of 'at least $8.89'; 'at least $9.00' on an Adjusted basis; the anticipated year-over-year decline results from the Star Ratings headwind for Bonus Year 2026, net of

    2/11/26 6:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    The Cigna Group Reports Strong Fourth Quarter and Full Year 2025 Results, Establishes 2026 Outlook and Increases Dividend

    Total revenues for 2025 increased 11% to $274.9 billionShareholders' net income for 2025 was $6.0 billion, or $22.18 per shareAdjusted income from operations1 for 2025 was $8.0 billion, or $29.84 per share2026 adjusted income from operations1 is projected to be at least $7.950 billion, or at least $30.25 per share2Board of Directors declared an increase in the quarterly dividend to $1.56 per shareBLOOMFIELD, Conn., Feb. 5, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today reported 2025 results, underscoring operational discipline and the strength of its complimentary portfolio of global health businesses.

    2/5/26 6:00:00 AM ET
    $CI
    Medical Specialities
    Health Care

    MetLife Announces Full Year and 4Q 2025 Results

    MetLife, Inc. (NYSE:MET) today announced its full year and fourth quarter 2025 results. Earnings   Return   Per Share on Equity (ROE     4Q 2025   4Q 2025 Net Income $1.17 ROE 12.0%   Adjusted Earnings $2.49 Adjusted ROE 17.6% Full Year Results Net income was $3.2 billion, or $4.71 per share. Adjusted earnings per share, excluding total notable items, up 10%1 to $8.89. Premiums, fees and other revenues (PFOs) increased 10% to $57.6 billion. Adjusted PFOs, excluding pension risk transfers (PRT), were up 5% to $49.8 billion. RIS record sales,

    2/4/26 4:15:00 PM ET
    $MET
    Life Insurance
    Finance